Access Ostase— 510(k) K232904
Substantially EquivalentBeckman Coulter
FDA 510(k) clearance K232904 for Access Ostase, Substantially Equivalent on 2024-04-15. Applicant: Beckman Coulter.
Clearance details
- Applicant
- Beckman Coulter
- Product code
- Code CIN
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Chaska, MN, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.